IDT.AX (IDT Australia Limited ASX) +25.58% to A$0.054 on 19 Feb 2026: momentum

IDT.AX stock jumped 25.58% intraday to A$0.054 on 19 Feb 2026 on a sharp volume spike, making it one of the ASX’s top gainers this session. Trading volume hit 839,788 versus an average 157,549, giving a relative volume of 5.33 and signalling strong short-term interest. The move follows comparative sector chatter and data listings rather than a single confirmed corporate announcement, so traders are watching momentum and liquidity for follow-through.

Intraday drivers for IDT.AX stock

The immediate catalyst for the IDT.AX stock move was heavy trading rather than a formal results release. Price opened at A$0.048, hit a day high of A$0.054 and closed well above yesterday’s A$0.043. Market participants are referencing comparative screens and competitor reports on Investing.com as context for renewed interest source. We link the intraday volume surge to short-covering and speculative flows rather than confirmed earnings surprises.

Valuation and financials driving the IDT.AX stock view

IDT Australia Limited (IDT.AX) trades with a market cap near A$23.08m and EPS of -0.02, producing a trailing PE of -2.70. Price-to-book sits at 1.05 and price-to-sales near 1.17. The company shows a current ratio of 2.94, cash per share A$0.0096, and book value per share A$0.0513. Revenue-per-share is A$0.0463, while net income per share is -A$0.0189, underscoring recovery revenue but negative profitability.

Technical picture and trading signals for IDT.AX stock

Technically, short-term indicators show positive momentum: RSI 60.13, ADX 30.85 (strong trend), and CCI 230.41 (overbought). The 50-day average (A$0.0507) sits below price while the 200-day average (A$0.0700) remains higher, indicating a mixed intermediate trend. High relative volume (839,788 vs 157,549) supports the breakout attempt, but on-chain liquidity and on‑balance volume are still negative, so confirmation over the next sessions is needed.

Meyka AI rating and analyst context

Meyka AI rates IDT.AX with a score out of 100: 63.90 (Grade B, Suggestion: HOLD). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. External company ratings on data feeds note mixed fundamentals; corporate-level strengths include stable gross margins (~49.04%) and decent current liquidity, while profitability and cash flow remain pressured.

Price targets, forecasts and model outlook for IDT.AX stock

Meyka AI’s forecast model projects a yearly price near A$0.04803, compared with the current A$0.054, implying -11.08% to the model year target. Monthly and quarterly short-term projections sit at A$0.04. Practical trading levels: near-term resistance is A$0.08 (implied upside 48.15%), and hard support is the YTD low A$0.043 (implied downside -20.37%). Forecasts are model-based projections and not guarantees.

Risks and opportunities relevant to IDT.AX stock

Opportunities: IDT’s contract manufacturing and medicinal cannabis exposure can anchor new revenue, and FY revenue growth was strong at +90.71% year-on-year in the latest reported period. Risks: operating cash flow and free cash flow are negative per share (-A$0.0147 and -A$0.0177), days sales outstanding are long (123 days), and EPS remains negative. Investors should weigh small-market-cap volatility and sector weakness in Healthcare (ASX Healthcare YTD underperformance). Additional context and competitor comparisons appear on Investing.com source.

Final Thoughts

IDT.AX stock was the ASX intraday top gainer on 19 Feb 2026, rising 25.58% to A$0.054 on heavy volume (839,788). Short-term technicals point to momentum, but fundamentals still show negative EPS and negative free cash flow per share. Meyka AI’s forecast model projects a yearly price of A$0.04803, an implied -11.08% from today’s price, while a trader-oriented recovery target near A$0.08 would offer about 48.15% upside if momentum holds. Our Meyka grade (Score 63.90, Grade B, Suggestion: HOLD) balances sector headwinds with operational revenue growth. Traders should watch follow-through volume, quarterly cash flow updates, and receivables trends before shifting allocation. Forecasts are model-based projections and not guarantees; conduct your own checks and consider position sizing for volatility. For live quote and charting see IDT.AX on Meyka IDT.AX on Meyka.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.